ReviewJournal of clinical medicine2025
SGLT2 Inhibitors: The First Endothelial-Protector for Diabetic Nephropathy.
Davide Viggiano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewJournal of clinical medicine2025
Davide Viggiano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.